Dr. McKay on the Real-World Utilization of Radium-223 in mCRPC

Rana R. McKay, MD, assistant professor of medicine and medical oncologist at the University of California, San Diego, discusses results from an analysis examining the real-world utilization of radium-223 (Xofigo) in metastatic castration-resistant prostate cancer.

Website:
Twitter:
Facebook:
LinkedIn:

cancer,oncology,